Objective-Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like chronic renal insufficiency, rheumatoid arthritis, and atherosclerosis. Recent findings revealed that advanced oxidation protein products are inhibitors of the major high-density lipoprotein receptor, scavenger receptor class B, type 1 (SR-BI). Here, we investigated which oxidation-induced structural alterations convert plasma albumin into a highdensity lipoprotein-receptor inhibitor. Approach and Results-Exposure of albumin to the physiological oxidant, hypochlorous acid, generated high-affinity SR-BI ligands. Protection of albumin-lysine residues before exposure to hypochlorous acid as well as regeneration of N-chloramines after oxidation of albumin completely prevented binding of oxidized albumin to SR-BI, indicating that modification of albumin-lysine residues is required to generate SR-BI ligands. Of particular interest, N-chloramines within oxidized albumin promoted irreversible binding to SR-BI, resulting in permanent receptor blockade. We observed that the SR-BI inhibitory activity of albumin isolated from chronic kidney disease patients correlated with the content of the myeloperoxidase-specific oxidation product 3-chlorotyrosine and was associated with alterations in the composition of high-density lipoprotein. 
N eutrophils are the first line of defense against invading microorganisms and thus accumulate in high numbers at sites of tissue injury. Neutrophils contain myeloperoxidase (MPO), which is released from activated neutrophils by intraluminal degranulation. MPO catalyzes the production of reactive chlorinating species like the powerful oxidant hypochlorous acid (HOCl). 1, 2 Reaction of chlorinated oxidants with plasma proteins leads to formation of advanced oxidation protein products. 3, 4 Previous studies have shown that plasma albumin may consume the majority of chlorinated oxidants with limited damage to other materials. 5 Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like end-stage renal disease (ESRD), atherosclerotic coronary artery disease, acute-on-chronic liver failure, and rheumatoid arthritis. 6, 7 Moreover, massive oxidation of plasma albumin was demonstrated by mass spectrometry in primary nephritic syndrome involving almost complete sulfonation of the free sulfhydryl group of Cys34. 8, 9 HOCl modifies proteins by various ways, including conversion of cysteine residues to disulphides and higher oxidation products, conversion of methionine residues to methionine sulphoxides, oxidation of tryptophan, and chlorination of amino groups and tyrosine. 10, 11 Given that plasma contains ≈100-fold excess of free amines over thiols, protein-associated N-chloramines are expected to be a major product of HOCl. N-chloramines can subsequently decompose to carbonyls via loss of hydrochlorous acid and hydrolysis of the resultant imine. 12, 13 Albumin isolated from patients with ESRD on hemodialysis (HD), but not albumin isolated from healthy controls, markedly inhibits high-density lipoprotein (HDL) association to scavenger receptor class B type I (SR-BI), 14 indicating that an oxidized fraction of albumin present in uremic blood is recognized by the receptor. SR-BI is expressed in hepatocytes and Kupffer cells of the liver and steroidogenic glands, as well as in endothelial cells, macrophages, and dendritic cells. [15] [16] [17] Several studies have shown that SR-BI is protective against atherosclerotic cardiovascular disease by acting as the primary pathway for disposal of HDL-associated cholesteryl esters (CE). 18, 19 In addition, studies in SR-BI-deficient mice demonstrate the importance of SR-BI expression for α-tocopherol and nitric oxide metabolism, normal red blood cell maturation, and female fertility. 18 More recently, it has been discovered that the HDL-SR-BI tandem serves other cardioprotective mechanisms, such as promoting endothelial repair and platelet function. 20, 21 In this study, we demonstrate that HOCl-induced N-chloramine formation generates SR-BI inhibitors that can irreversibly block the receptor. The present results provide further evidence that MPO-catalyzed protein damage may contribute to the pathophysiology of cardiovascular disease.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Modification of Albumin-Lysine Residues Transforms Albumin into an SR-BI Inhibitor
Oxidized plasma albumin is formed by MPO-derived HOCl in vivo. 3, [22] [23] [24] Conversion of positively charged ε-amino groups of lysine residues by HOCl results in loss of positive charge through formation of chloramines. The resulting increase in negative charge might affect the interaction of albumin with SR-BI. To specifically elucidate the role of lysine residues, lysine amine groups were either methylated before oxidation to prevent lysine chlorination or free methionine was added to HOCl-treated albumin (chlorinated albumin) to reverse N-chloramine formation. 25 HOCl-modification of albumin generated SR-BI ligands, which effectively inhibited Alexa and control CHO cells (LdlA7) were incubated at 37°C for 2 hours with Alexa Fluor 488 (AF488)-labeled high-density lipoprotein (HDL) (50 μg/mL) in the presence of either 1 mg/mL native albumin or HOCl-albumin. To protect lysine residues from oxidation, albumin was methylated before oxidation (methylated albumin). HOCl-induced lysine-chloramine formation was reversed by addition of excess free L-methionine 30 minutes after HOCl treatment of albumin (albumin+L-methionine) ***P<0.001 vs native albumin. B, LdlA(SR-BI) and LdlA7 cells were incubated at 37°C for 4 hours with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-HDL (50 μg/mL) in the presence of 1 mg/mL native albumin or HOCl-albumin. Albumin was oxidized for either 30 minutes at 4°C or for 5 days at 37°C to allow N-chloramine decomposition (aged albumin). To reverse HOCl-induced lysine-chloramine formation, L-methionine was added in excess 30 minutes after the incubation period (albumin+L-methionine). ***P<0.001 vs native albumin of the respective set of samples. C, LdlA(SR-BI) and LdlA7 cells were incubated at 37°C for 2 hours with AF488-HDL (50 μg/mL) in the presence of 1 mg/mL native albumin, HOCl-albumin, carbamylated albumin (homocitrulline [HCit]-albumin), or carboxymethylated albumin (carboxymethyllysine [CML]-albumin). The extent of modified lysine residues was comparable throughout the different albumin preparations (≈6 modified lysine residues of 59). ***P<0.001 vs native albumin. D, LdlA(SR-BI) and LdlA7 cells were incubated at 37°C for 2 hours with AF488-HDL (50 μg/mL) in the presence of 1 mg/mL HOCl-albumin or HCitalbumin preparations containing indicated modified lysine residues per albumin.*P<0.05; ***P<0.001 vs 100% AF488-HDL association. E, LdlA(SR-BI) and LdlA7 cells were incubated at 37°C for 4 hours with DiI-HDL (50 μg/mL) in the presence or absence of plasma which was spiked with indicated concentrations of HOCl-albumin. ***P<0.001 vs plasma in the absence of oxidized albumin. A-E, AF488-HDL association to SR-BI and DiI-HDL uptake by SR-BI were assessed by flow cytometry. AF488-HDL association to SR-BI and DiI-HDL uptake by SR-BI, in the absence of any competitor, were set to 100%. Average fluorescence values measured in LdlA7 cells were subtracted from those measured in LdlA(SR-BI) cells to calculate SR-BI-specific HDL association and uptake. Data are represented as mean±SEM of at least 2 independent experiments performed in triplicates. F, BALB/c mice (n=6) were injected via the tail vein with a mixture of 50 Fluor 488 (AF488) labeled HDL binding to SR-BI in competition experiments ( Figure 1A ). However, when lysine residues of albumin were methylated before oxidation, the oxidation product did not interfere with HDL binding to SR-BI. Methionine treatment efficiently regenerated albumin-lysine residues (Figure III in the online-only Data Supplement) and completely averted HDL displacement by oxidized albumin in competition experiments ( Figure 1A ). This clearly indicates that N-chloramine formation transforms albumin into an SR-BI inhibitor.
Next, we investigated whether albumin containing N-chloramines affects SR-BI-mediated HDL-lipid uptake. To address this question, we performed competition experiments with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-labeled HDL (lipid moiety label) in the presence of native and oxidized albumin ( Figure 1B ). In line with results shown in Figure 1A , HOCl-albumin effectively attenuated SR-BI-mediated HDL-lipid uptake, which was not observed when methionine was added to reverse N-chloramine formation ( Figure 1B ). Chloramines gradually decompose to carbonyls via the loss of hydrochlorous acid and hydrolysis of the imine. 12, 13 To study the impact of N-choramines on HDL-lipid delivery, HOCl-albumin was incubated for 5 days at 37°C to allow complete decomposition of N-chloramines and N-chloramine-derived carbonyls. The resulting aged HOCl-albumin preparations were used for further competition experiments. Both freshly oxidized albumin and aged HOCl-albumin clearly reduced SR-BI-mediated DiI-HDL uptake ( Figure 1B ). However, only the inhibitory effect mediated by freshly oxidized albumin was reversed on addition of methionine. Based on these results, we assume that both chloramines and their decomposition products transform albumin into an SR-BI inhibitor. To test whether positive charge elimination through lysine modification by principle renders albumin an SR-BI ligand, albumin-lysine residues were carbamylated with cyanate-yielding homocitrulline (HCit) and carboxymethylated to form carboxymethyllysine (CML). To confirm that albumin-lysine residues were modified to about the same extent throughout the 3 different albumin modifications, lysine modification was determined using amino acid analysis and liquid chromatography tandem mass spectrometry. In competition experiments, HCit-albumin displaced HDL from SR-BI ( Figure 1C ), providing further evidence that lysine modification is required to generate SR-BI ligands. Surprisingly, CML-albumin failed to interfere with HDLbinding to SR-BI, suggesting that the negative charge of the carboxyl-group of CML and structural differences of CML prevent binding to SR-BI ( Figure IV in the online-only Data Supplement). We observed that already a modification of >2 of 59 lysine residues in HOCl-albumin was sufficient to generate SR-BI inhibitors, whereas HCit-albumin was less effective with regard to the number of modified lysine residues ( Figure 1D) .
Based on the assumption that only a fraction of plasma albumin is more extensively modified, we intended to determine the proportion of oxidized albumin necessary to block SR-BI. Notably, already the presence of <1% oxidized albumin in plasma effectively inhibited SR-BI-mediated DiI-HDL uptake ( Figure 1E ). To demonstrate in vivo relevance of our data, we examined the plasma clearance of 3 H-CE-HDL coinjected with either native albumin or oxidized-albumin in mice. We found that HOCl-albumin significantly impaired 
HOCl-Albumin Irreversibly Binds to SR-BI
Prompted by the observation that HOCl-albumin was a more effective SR-BI inhibitor than HCit-albumin, we assessed binding affinities of modified AF488-labeled albumin preparations to SR-BI. To inhibit receptor internalization, binding experiments were performed at 4°C. Surprisingly, binding affinities of HCit-albumin and HOCl-albumin to SR-BI were similar (Kd-values, HOCl-albumin 47.1±6.3 μg/mL; HCit-albumin, 34.2±5.2 μg/mL), although their dissociation characteristics clearly differed (Figure 2A and 2B ). About 90% of chlorinated albumin remained associated to SR-BI even after >20 hours, whereas the major portion of bound HCitalbumin dissociated ( Figure 2B ).
Moreover, a 30-fold molar excess of HOCl-albumin was not able to displace AF488 HOCl-albumin from SR-BI ( Figure 3A) . In contrast, labeled HCit-albumin was effectively displaced by either HCit-albumin or HOCl-albumin ( Figure 3B ). Taken together, these results point to an irreversible binding of HOCl-albumin to SR-BI. Similar results were obtained when plasma was spiked with AF488-albumin Figure 2 . Concentration-dependent association of modified albumin to scavenger receptor class B type I (SR-BI). A, LdlA(SR-BI) and LdlA7 cells were incubated with the indicated concentrations of oxidized or carbamylated Alexa Fluor 488 (AF488)-albumin for 2 hours at 4°C, and AF488-albumin association was assessed by flow cytometry. SR-BI-specific AF488-albumin association was calculated as described above. Data are represented as mean±SEM of at least 2 independent experiments performed in triplicates. Native AF488-labeled albumin showed no binding to SR-BI (data not shown). B, Dissociation of modified albumin. LdlA(SR-BI) and LdlA7 cells were incubated with 100 μg/mL oxidized or carbamylated AF488-albumin for 2 hours at 4°C. Subsequently, cells were washed and incubated with medium containing native albumin (3 mg/mL) for up to 22 hours. The remaining cell-associated AF488-albumin was assessed by flow cytometry, and SR-BI-specific AF488-albumin binding was assessed. Data are shown as mean±SEM of 2 independent experiments performed in triplicate. **P=0.0085 vs carbamylated albumin. To explore the relevance of N-chloramines for irreversible binding, HOCl-albumin was incubated for 5 days at 37°C (aged albumin) to allow complete decomposition of chloramines and N-chloramine-derived carbonyls as described above. Notably, aged HOCl-albumin was displaced from SR-BI by excess HOCl-albumin, indicating that albumin-chloramines mediate irreversible receptor association ( Figure 3C ).
HOCl-Modified Albumin Cross-Links With SR-BI
To test whether oxidized albumin covalently cross-links with SR-BI, HOCl-albumin-treated SR-BI overexpressing cells and control cells were lysed, and Western blot analysis was performed. Immunochemical detection of SR-BI on blotted membranes revealed a broad and diffuse high-molecular weight band, presumably indicating SR-BI/HOCl-albumin cross-links (Figure 4) . Importantly, the high-molecular weight band was not detected when control LdlA7 cells were treated with HOCl-albumin or when SR-BI overexpressing cells were treated with native albumin. Given that the high-molecular weight band of SR-BI was much less intense when SDS-PAGE was performed under reducing conditions, disulphide bonds might, at least in part, mediate the irreversible binding of HOCl-albumin to SR-BI.
Because of its susceptibility to oxidation, it is conceivable that oxidative modification of the free cysteine residue (Cys34) of albumin affects intermolecular cross-link formation with SR-BI. To address this notion, albumin-cysteine residues were alkylated using iodoacetamide before HOCl treatment. 26 However, competition experiments revealed that alkylating the free cysteine residue of albumin did not inhibit irreversible binding, suggesting that Cys34 oxidation is not required for cross-link formation ( Figure VII in the onlineonly Data Supplement).
HOCl-Albumin Colocalizes With SR-BI in LdlA(SR-BI) Cells
To assess whether cells internalize SR-BI/HOCl-albumin complexes, LdlA(SR-BI) and control LdlA7 cells were incubated with AF488-labeled HOCl-albumin for immunohistochemical analysis. Immunohistochemical staining showed that AF488-labeled HOCl-albumin exhibited intracellular colocalization with SR-BI in LdlA(SR-BI) cells, suggesting receptor internalization and efficient uptake of HOCl-albumin ( Figure 5 ). SR-BI association of native AF488-albumin was insufficient to be detected under these experimental A, LdlA(SR-BI) and LdlA7 cells were incubated with 100 μg/mL Alexa Fluor 488 (AF488)-labeled-HOCl-albumin for 2 hours at 4°C. After washing, cells were incubated for another 2 hours with a 30-fold molar excess of native or HOCl-albumin (B) LdlA(SR-BI) and LdlA7 cells were incubated with 100 μg/mL AF488-labeled HCit-albumin for 2 hours at 4°C. After washing, cells were incubated for another 2 hours with a 30-fold molar excess of native, HCit-albumin or HOCl-albumin. *P<0.05; **P<0.01 vs native albumin; (C) albumin was oxidized and incubated for 5 days at 37°C to allow N-chloramine decomposition (aged HOCl-albumin). Subsequently, LdlA(SR-BI) and LdlA7 cells were incubated with 100 μg/mL of the labeled albumin preparation for 2 hours at 4°C. After washing, the cells were incubated for another 2 hours with a 30-fold molar excess of native or HOCl-albumin. ***P<0.001 vs native albumin; association of AF488-labeled albumin was measured by flow cytometry, and SR-BI-specific binding was assessed. Data are shown as mean±SEM of 2 independent experiments performed in triplicate. ) and LdlA7 cells were incubated with 1 mg/mL native or HOCl-albumin for 2 hours at 37°C. Cells were rinsed, lysed, and cell lysates were subjected to SDS-PAGE under reducing and not-reducing conditions. Separated proteins were transferred onto polyvinylidene difluoride membranes for SR-BI detection.
conditions. Control LdlA7 cells showed very low uptake of HOCl-albumin ( Figure 5 ).
The SR-BI Inhibitory Activity of Albumin Isolated From Patients With ESRD Correlates With the Content of 3-Chlorotyrosine and the Composition of HDL
MPO may not only oxidize proteins locally in inflamed tissue sections, as evidenced by increased levels of circulating advanced oxidation protein products described in chronic inflammatory diseases, like chronic kidney disease. 3 Accord ingly, we isolated albumin from patients with ESRD on HD and determined levels of the MPO fingerprint 3-chlorotyrosine. A more detailed characterization of isolated albumin is given in Table II in the online-only Data Supplement. In line with previous results, 14 we observed that HD-albumin interferes with 125 I-HDL binding to SR-BI ( Figure 6A) . Here, we demonstrate that the SR-BI inhibitory activity of HD-albumin, measured as the efficacy to attenuate 125 I-HDL association to SR-BI, significantly correlated with the MPO-specific oxidation product 3-chlorotyrosine ( Figure 6B) . A previous study reported that SR-BI deficiency in mice resulted in the accumulation of CE-enriched and phospholipid (PL)-depleted HDL particles. 27 We wondered whether blockade of SR-BI through HD-albumin might be associated with an altered HDL-lipid composition in patients with ESRD. To address this question, we isolated HDL from plasma of controls and patients with ESRD, assessed the HDL-CE and HDL-PL content, and examined the relationship between the SR-BI inhibitory activity of HD-albumin and the HDL-CE/PL ratio. Of particular interest, we observed that the SR-BI inhibitory activity of HD-albumin significantly correlated with the CE/PL composition of isolated HDL ( Figure 6C ).
Discussion
MPO released by degranulation of activated human neutrophils avidly binds to cell membrane glycosaminoglycans, therefore plasma protein oxidation in close vicinity to cells may have important implications for the regulation of cellular function during inflammation. 28 Of particular interest, MPO may not only locally oxidize proteins, as shown by increased levels of circulating advanced oxidation protein products described in several chronic inflammatory diseases. 6, 7 Our study provides the novel evidence that HOCl-induced oxidation of plasma albumin generates irreversible HDLreceptor inhibitors. Previous studies referred to cysteine oxidation as a trigger of HOCl-induced intramolecular and intermolecular sulfenamide, sulfinamide, and sulfonamide generation. 29, 30 Our results suggest that oxidation of Cys34 in albumin is unlikely to be involved in cross-link formation with SR-BI, because methylation of Cys34 before oxidation did not inhibit irreversible binding to the receptor. However, given that 2 of the 6 exoplasmic cysteines of SR-BI are free thiol groups (Cys251 and Cys384), 31 it is tempting to speculate that albumin-chloramines may oxidize SR-BI Cys251 and Cys384, thereby forming labile intermolecular sulfenamides or more oxidized sulfinamides/sulfonamides. In line with that assumption is the finding that N-chloramines preferentially react with cysteine residues in plasma and isolated proteins. 32 It is of interest to note that protein thiols are decreased in a number of inflammatory diseases, 6, 7 which could be attributable to generation of long-lived, thiol-specific N-chloramine derivatives of HOCl. 32 When SR-BI overexpressing cells were incubated with HOCl-albumin, we detected high-molecular weight complexes containing SR-BI by Western blot analysis. Addition of mercaptoethanol markedly reduced the highmolecular weight bands, favoring the assumption that free Cys251 and Cys384 residues of SR-BI may contribute to the HOCl-albumin/SR-BI cross-link formation. However, further studies are required to fully clarify the underlying mechanism(s). A previous study reported that HOCl may induce protein aggregation attributable to strong, noncovalent interactions between oxidized protein chains. 33 Other studies have proposed cross-linking via dityrosine formation or Schiff base formation between proteins through chloraminederived aldehydes and lysine residues. 34 In the present study, we observed that HOCl-albumin, which was incubated at and LdlA7 cells were incubated with 100 μg/mL AF488-labeled native or HOClalbumin for 2 hours at 37°C. Cells were rinsed, fixed with 2% paraformaldehyde for 30 minutes, and permeabilized with Triton X100 in PBS for 15 minutes. Anti-SR-BI antibody (1:300 in PBS/5% BSA) was applied for 3 hours at room temperature under light exclusion and without prior washing. Texas Red-coupled goat antirabbit IgG (1:500 in PBS/5% BSA) was used as secondary antibody.
37°C to induce break-down of chloramines, reversibly binds to SR-BI. Given that N-chloramines decompose into the carbonyl aminoadipic semialdehyde, Schiff base formation may not significantly contribute to albumin-SR-BI cross-link formation.
HOCl reacts with amines at a lower rate than with thiols. 35 On the other hand, plasma contains ≈100-fold excess of free amines over thiols, therefore a considerable number of protein-associated N-chloramines are expected to be formed. HOCl-mediated oxidation of the major plasma protein, albumin, was previously investigated, both experimentally and computationally, predicting that plasma proteins consume the majority of HOCl with limited damage to other materials. 5 Ascorbate or α-tocopherol, even at levels achieved in human supplementation studies, do not attenuate these reactions. On the contrary, elevated thiocyanate levels, as detected in heavy smokers, can modulate HOCl-mediated reactions resulting in the formation of hypothiocyanous acid and cyanate, which causes protein carbamylation and oxidation of thiol groups. [36] [37] [38] [39] In addition, MPO was shown to promote formation of glycolaldehyde and other reactive aldehydes and may therefore play a pathogenic role by generating advanced glycation end-products like CML. 12, 40 Modification/oxidation of lysine residues alters structural properties of proteins through elimination of positive charge, thereby affecting protein-water interaction or protein-protein interaction. Although oxidation and carbamylation neutralize the positive charge on the amino group of lysine, reductive methylation selectively modifies lysine residues of albumin without altering the positive charge. Interestingly, when reductively methylated albumin was oxidized with HOCl, it did not bind to SR-BI, despite oxidation of cysteine, methionine, tyrosine, histidine, and arginine residues. 11 This clearly supports the idea that alterations in the particular distribution of charged lysine residues through post-translational modifications may be crucial for the transformation of albumin into an SR-BI ligand. Given that HOCl-albumin is recognized by the receptor for advanced glycation end-products and CD36, 23, 41 our data raise the possibility that HOCl-modified albumin also irreversibly cross-links with these receptors. Of particular interest, intravenous injections of HOCl-albumin in unilateral nephrectomy rats activated the intrarenal renin-angiotensin system via a CD36-mediated pathway and induced podocyte apoptosis in mice via the receptor of advanced glycation end-products. 41, 42 The observation that SR-BI can be irreversibly blocked by oxidized albumin may be of particular relevance, because SR-BI expressed on hepatocytes functions as a positive regulator of cholesterol efflux from macrophages. 43 Therefore, oxidized/modified albumin might contribute to cholesterol retention in the arterial wall and alter composition of HDL, as observed in the present study. This is in accordance with recent studies reporting that compositional alterations in HDL may significantly impair HDL functionality in ESRD. 44, 45 In addition, SR-BI is highly expressed in lipid-laden macrophages in atherosclerotic tissue 46 ; hence blockade of SR-BI-mediated cholesterol efflux may contribute to foam cell formation in the vessel wall. Besides the importance of SR-BI in reverse cholesterol transport, the HDL-SR-BI tandem confers additional atheroprotective actions. For instance, HDL binding to SR-BI protects endothelial cells from apoptosis. 20 A previous study reported that treatment of hypercholesterolemic rabbits with repeated intravenous injections of HOCl-albumin significantly increased macrophage infiltration and smooth muscle cell proliferation in atherosclerotic plaques. Interestingly, this was associated with significantly increased plasma total cholesterol, which is mainly carried by HDL in rabbits. 47 In conclusion, the present study demonstrates that modified lysine residues mediate albumin-SR-BI interaction and that N-chloramines transform plasma albumin into an irreversible SR-BI inhibitor. Blockade of SR-BI through oxidized plasma albumin may alter HDL composition and probably HDL functionality. Given that several potential atheroprotective activities of HDL are mediated by SR-BI, a permanent SR-BI blockade may therefore contribute to the pathophysiology of cardiovascular disease.
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